Search research articles
Contact Us
Filters
Showing results (51-60 of 54) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 54 results.
Journal of Viral Hepatitis
|
July 17, 2001
African Americans with genotype 1 treated with interferon for chronic hepatitis C have a lower end of treatment response than Caucasians
J L Kinzie, P H Naylor, M G Nathani, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 1, 1990
Cellular levels of thymosin immunoreactive peptides are linked to proliferative events: evidence for a nuclear site of action
C N Conteas, M G Mutchnick, K C Palmer, et al.
Journal of Viral Hepatitis
|
June 10, 2000
Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States
L M Blatt, M G Mutchnick, M J Tong, et al.
Journal of Viral Hepatitis
|
December 22, 1999
Thymosin alpha1 treatment of chronic hepatitis B: results of a phase III multicentre, randomized, double-blind and placebo-controlled study
M G Mutchnick, K L Lindsay, E R Schiff, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 54) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 54 results.
Journal of Viral Hepatitis
|
July 17, 2001
African Americans with genotype 1 treated with interferon for chronic hepatitis C have a lower end of treatment response than Caucasians
J L Kinzie, P H Naylor, M G Nathani, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 1, 1990
Cellular levels of thymosin immunoreactive peptides are linked to proliferative events: evidence for a nuclear site of action
C N Conteas, M G Mutchnick, K C Palmer, et al.
Journal of Viral Hepatitis
|
June 10, 2000
Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States
L M Blatt, M G Mutchnick, M J Tong, et al.
Journal of Viral Hepatitis
|
December 22, 1999
Thymosin alpha1 treatment of chronic hepatitis B: results of a phase III multicentre, randomized, double-blind and placebo-controlled study
M G Mutchnick, K L Lindsay, E R Schiff, et al.
Page
of 6